FDA Approves Izervay for Geographic Atrophy Tied to Age-Related Macular Degeneration
WEDNESDAY, Aug. 9, 2023 (HealthDay News) — The U.S. Food and Drug Administration has approved Izervay (avacincaptad pegol intravitreal solution) for the treatment of geographic atrophy secondary to age-related macular degeneration.The approval was ba…
Learn MoreAmsler Grid Not Sensitive Enough for Diagnosing Neovascular AMD
MONDAY, Feb. 27, 2023 (HealthDay News) — The Amsler grid has a sensitivity of 67 percent for diagnosing neovascular age-related macular degeneration (AMD) compared with healthy controls, according to a systematic review and meta-analysis published on…
Learn MoreFDA Approves First Treatment for Geographic Atrophy
FRIDAY, Feb. 24, 2023 (HealthDay News) — Pegcetacoplan (SYFOVRE) has been approved by the U.S. Food and Drug Administration as the first and only treatment for geographic atrophy (GA), an advanced form of age-related macular degeneration.Pegcetacopl…
Learn MoreU.S. Adults Lack Knowledge About Age-Related Macular Degeneration
WEDNESDAY Feb. 8, 2023 (HealthDay News) — Most U.S. adults are unaware of warning signs of age-related macular degeneration (AMD) and treatment advances for the condition, according to survey results released by the American Society of Retina Special…
Learn MoreU.S. Adults Lack Knowledge About Age-Related Macular Degeneration
WEDNESDAY Feb. 8, 2023 (HealthDay News) — Most U.S. adults are unaware of warning signs of age-related macular degeneration (AMD) and treatment advances for the condition, according to survey results released by the American Society of Retina Special…
Learn MoreTwo Disease Processes Contribute to Age-Related Macular Degeneration
FRIDAY, Jan. 13, 2023 (HealthDay News) — Two processes seem to contribute to age-related macular degeneration (AMD), according to a study published online Jan. 9 in Eye.Wei Wei, M.D., from the Icahn School of Medicine at Mount Sinai in New York City,…
Learn MoreDietary Nitrate Intake Linked to Lower Risk for AMD Progression
WEDNESDAY, Dec. 28, 2022 (HealthDay News) — Dietary nitrate intake is associated with a lower risk for progression of age-related macular degeneration (AMD), according to a study published online Dec. 22 in JAMA Ophthalmology.Geoffrey K. Broadhead, M…
Learn MoreLa elección de fármaco podría ser importante para los pacientes con degeneración macular
MIÉRCOLES, 7 de diciembre de 2022 (HealthDay News) — Uno de los dos medicamentos más comunes usados para tratar la degeneración macular asociada con la edad (DMAE) parece ser mejor que el otro, sugiere un nuevo estudio de tamaño reducido.Entre 106 pa…
Learn MoreDrug Choice Might Matter for Patients With Macular Degeneration
WEDNESDAY, Dec. 7, 2022 (HealthDay News) — One of the two most common drugs used to treat age-related macular degeneration (AMD) appears better than the other, a new, small study suggests.Among 106 patients with “wet” age-related macular degeneration…
Learn MoreSubretinal Drusenoid Deposits Linked to High-Risk Vascular Disease in AMD
FRIDAY, Nov. 18, 2022 (HealthDay News) — In patients with age-related macular degeneration (AMD), subretinal drusenoid deposits (SDD) are associated with high-risk vascular diseases (HRVD), according to a study published online Nov. 17 in BMJ Open Op…
Learn More